Categories: Latest

Apollo Hospitals Group firm to sell 23% in Apollo Munich

Hyderabad, January 28, 2016: The board of directors of Apollo Energy Company Ltd, an Apollo Hospitals Group company, has approved the divestment of 23.3 per cent stake in Apollo Munich Health Insurance to its joint venture partner, Munich Re of Germany for ₹163.5 crore.

The proposed transaction values Apollo Munich at ₹703 crore. Completion of the proposed transaction, subject to regulatory approvals and execution of customary agreements, is expected to be completed at the end of the first quarter of 2016.

Post consummation of the transaction, Apollo Hospitals Group’s shareholding in Apollo Munich shall come down from 74.4 per cent to 51.1 per cent. Correspondingly, Munich Re’s shareholding in Apollo Munich shall move to 48.7 per cent and 0.2 per cent will be held by employees. Apollo Hospitals shall continue to hold its stake in Apollo Munich.

Prathap C Reddy, Chairman, Apollo Munich Health Insurance Company Ltd and Chairman, Apollo Hospitals Enterprise Ltd, in a statement said:, “Insurance is a key element for making quality healthcare facilities accessible to the masses. The show of confidence from our JV partner will go a long way in helping the Group achieve its vision of ‘Healthcare for all’.”

Doris Höpke, member of the Munich Re Board of Management responsible for Munich Health, said: “India’s population structure, increased life expectancy and positive economic development will usher in a steep rise in medium-term healthcare spending. Since its start in 2007, Apollo Munich Health Insurance has shown exceptional, often above-market growth rates. With the increased stakeholding, we are strengthening our position for sustainable and profitable growth in this region. Apollo Munich Health Insurance is committed to make quality healthcare easy and accessible.”

Munich Re is able to increase its stake following the Centre’s decision in March 2015 to increase the foreign direct investment cap in the insurance sector from 26 per cent to 49 per cent.

With the increase in shareholding, Munich Re strengthens its presence in India, which is one of the key markets for the company.

Axis Capital acted as the financial advisor for the transaction.-V Rishi Kumar, BusinessLine

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

2 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

2 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

3 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

3 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago